Source:http://linkedlifedata.com/resource/pubmed/id/19749800
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
45
|
pubmed:dateCreated |
2009-11-12
|
pubmed:abstractText |
MicroRNAs (miRNAs) are small non-coding RNAs involved in the regulation of critical cell processes such as apoptosis, cell proliferation and differentiation. A small set of miRNAs is differentially expressed in hematopoietic cells and seemingly has an important role in granulopoiesis and lineage differentiation. In this study, we analysed, using a quantitative real-time PCR approach, the expression of 12 granulocytic differentiation signature miRNAs in a cohort of acute promyelocytic leukemia (APL) patients. We found nine miRNAs overexpressed and three miRNAs (miR-107, -342 and let-7c) downregulated in APL blasts as compared with normal promyelocytes differentiated in vitro from CD34+ progenitors. Patients successfully treated with all-trans-retinoic acid (ATRA) and chemotherapy showed downregulation of miR-181b and upregulation of miR-15b, -16, -107, -223, -342 and let-7c. We further investigated whether the APL-associated oncogene, promyelocytic leukemia gene (PML)/retinoic acid receptor alpha (RARalpha), might be involved in the transcriptional repression of miR-107, -342 and let-7c. We found that PML/RARalpha binds the regulatory sequences of the intragenic miR-342 and let-7c. In addition, we observed, in response to ATRA, the release of PML/RARalpha paralleled by their transcriptional activation, together with their host genes, EVL and C21orf34alpha. In conclusion, we show that a small subset of miRNAs is differentially expressed in APL and modulated by ATRA-based treatment.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1476-5594
|
pubmed:author |
pubmed-author:BlandinoGG,
pubmed-author:CarecciaSS,
pubmed-author:DiverioDD,
pubmed-author:GurtnerAA,
pubmed-author:LavorgnaSS,
pubmed-author:LevreroMM,
pubmed-author:Lo-CocoFF,
pubmed-author:MainardiSS,
pubmed-author:PelosiAA,
pubmed-author:PelosiEE,
pubmed-author:PiaggioGG,
pubmed-author:RiccioniRR,
pubmed-author:RizzoM GMG,
pubmed-author:SacchiAA,
pubmed-author:TestaUU
|
pubmed:issnType |
Electronic
|
pubmed:day |
12
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4034-40
|
pubmed:meshHeading | |
pubmed:year |
2009
|
pubmed:articleTitle |
A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes.
|
pubmed:affiliation |
Laboratory of Molecular Oncogenesis, Department of Experimental Oncology, Regina Elena Cancer Institute, Rome 00158, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|